DIATHEVA is an Italian biotech company founded in 2002 with the aim to bring research into industrial products by cooperating with firms, public and private research institutions.
DIATHEVA focuses on development, production and marketing of new and innovative products (antibodies, recombinant proteins, immunoassays and SNPs detection kits) for diagnostics, research and therapeutic applications in the field of: Cancer, Microbial Infection and Pharmacogenetics.
DIATHEVA has a GMP authorized facility designed for the manufacture of APIs for pre-clinical and clinical trial studies with a special emphasis on new immunogens against HIV and other microbial pathogens
Print-Age is a POR MARCHE FESR 2014-2020 funded project (Asse 1 – Obiettivo Specifico 3 – Azione 3.1: “Promuovere soluzioni innovative per affrontare le sfide delle comunità locali nell’ambito della...Read more
DIATHEVA presented a new product in pipeline "scFv 2G8" at BIO CONVENTION 2016 in the context of a workshop dedicated to showcasing of novel antibiotics which was held the past 6 June...Read more